BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Jpmorgan Chase

BioCentury | May 10, 2024
Management Tracks

Nickerson to lead Therini as CEO

Plus: Alex Gorsky joins Iconiq Capital and updates from JPMorgan and Merakris
BioCentury | Oct 14, 2022
Politics, Policy & Law

Looking beyond Inflation Reduction Act, Biden order promises more drug pricing policies

Medicare to propose models to reduce drug prices
BioCentury | Jul 28, 2022
Politics, Policy & Law

Accountable healthcare: a conversation with Morgan Health’s Dan Mendelson

How employers have the ability, and responsibility, to reduce healthcare disparities, improve quality and lower the costs of healthcare
BioCentury | Jul 7, 2022
Politics, Policy & Law

U.S. moves closer to drug price regulation

Fate of Medicare drug price regulation, Part D reforms uncertain
BioCentury | Feb 16, 2018
Financial News

Berkshire Hathaway discloses Teva investment

BioCentury | Feb 15, 2018
Company News

Teva jumps on Berkshire Hathaway investment

BioCentury | Feb 5, 2018
Financial News

Biotech dips amid market sell-off

Items per page:
1 - 10 of 23
Username